Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 1, 2008
Prevalence of group C rotavirus among children in Rhode Island, United StatesMathew D Esona, Charles D Humphrey, Penelope H Dennehy, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 8, 2008
The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccinePenelope H Dennehy, Michelle G Goveia, Michael J Dallas, et al.Vaccine|September 21, 2010
Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USASachin N Desai, Daina B Esposito, Eugene D Shapiro, et al.The Pediatric Infectious Disease Journal|December 28, 2017
Nephrotoxicity With Vancomycin in the Pediatric Population: A Systematic Review and Meta-AnalysisTheresa M Fiorito, Megan K Luther, Penelope H Dennehy, et al.Pediatrics|November 4, 2008
Coadministration of RIX4414 oral human rotavirus vaccine does not impact the immune response to antigens contained in routine infant vaccines in the United StatesPenelope H Dennehy, Helen R Bertrand, Peter E Silas, et al.Journal of Virology|February 3, 2007
Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrheaYuhuan Wang, Penelope H Dennehy, Harry L Keyserling, et al.The Pediatric Infectious Disease Journal|August 24, 2017
Adverse Events Following Vaccination With Bivalent rLP2086 (Trumenba®): An Observational, Longitudinal Study During a College Outbreak and a Systematic ReviewTheresa M Fiorito, Grayson L Baird, Nicole Alexander-Scott, et al.Journal of American College Health : J of ACH|January 26, 2017
Rapid response to a college outbreak of meningococcal serogroup B disease: Nation's first widespread use of bivalent rLP2086 vaccineTheresa M Fiorito, Suzanne Bornschein, Alysia Mihalakos, et al.The Pediatric Infectious Disease Journal|November 12, 2005
Safety and immunogenicity of palivizumab (Synagis) administered for two seasonsDonald Null, Bernard Pollara, Penelope H Dennehy, et al.Human Vaccines|March 29, 2011
Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen)Penelope H Dennehy, Timo Vesikari, David O Matson, et al.Pageof 3